ResMed Inc. (RMD) Shareholders’ equity 2016–2025
ResMed Inc. (RMD) shareholders’ equity at each fiscal year-end, per SEC filings.
$6.0BFY2025 · since FY2016: $1.7B → $6.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.0B | +22.7% |
| FY2024 | $4.9B | +17.8% |
| FY2023 | $4.1B | +22.9% |
| FY2022 | $3.4B | +16.5% |
| FY2021 | $2.9B | +15.6% |
| FY2020 | $2.5B | +20.5% |
| FY2019 | $2.1B | +0.6% |
| FY2018 | $2.1B | +5.0% |
| FY2017 | $2.0B | +15.7% |
| FY2016 | $1.7B | — |
Source: SEC XBRL filings · For reference only · Not investment advice